Mounjaro Consultation in Seomyeon, Busan
A Mounjaro consultation (마운자로 상담) is a medical assessment for tirzepatide, a once-weekly injection that activates both GIP and GLP-1 receptors to reduce appetite and improve blood sugar control. In Seomyeon, Busan, the doctor reviews BMI, health conditions and medications, then explains pen use and dosing. Treatment starts at 2.5 mg and increases in steps every 4 weeks, with weight loss developing over months.
Independent patient guide · Medically informative, not a substitute for a doctor's advice · Last reviewed:
What is Mounjaro?
Mounjaro is the brand name for tirzepatide. Unlike semaglutide and liraglutide, which act on GLP-1 receptors only, tirzepatide also activates GIP receptors, another gut hormone pathway involved in appetite and insulin release. In clinical trials, tirzepatide produced large average weight reductions in people with obesity, and it also lowers blood sugar in type 2 diabetes. In some countries the weight-management version is sold under a different brand name; ask your clinic which product is prescribed.
Who is it for?
- Adults with obesity, or overweight with weight-related conditions, as defined in the approved prescribing information
- Adults with type 2 diabetes needing better glucose control (under diabetes care)
- People who have not reached goals with lifestyle changes alone
It is not suitable during pregnancy or breastfeeding. Women using oral contraceptives may need additional or alternative contraception during dose starts and increases, as absorption can be affected. History of pancreatitis, gallbladder disease or severe gastrointestinal disease needs discussion.
What happens at the clinic
- Assessment: weight history, BMI, waist, blood pressure, diabetes status and medications.
- Tests: HbA1c, lipids, kidney and liver function as appropriate.
- Safety review: thyroid cancer history, pancreatitis, contraception and pregnancy plans.
- Pen training: injection technique, rotation of sites and storage.
- Dose plan: gradual increases with follow-up roughly every 4 weeks.
Treatment outlook
Appetite reduction is often noticeable within weeks, while weight loss continues over many months as the dose increases. Not everyone needs the highest dose; the doctor aims for the lowest effective, tolerable dose. As with other GLP-1-based medicines, weight is often regained after stopping, so long-term plans matter.
Risks and side effects
- Gastrointestinal effects, most common during dose increases
- Gallbladder problems and, rarely, pancreatitis
- Dehydration and kidney strain with severe vomiting or diarrhea
- Low blood sugar when combined with insulin or sulfonylureas
- Muscle loss if protein intake and strength exercise are inadequate
Choosing a clinic for a Mounjaro consultation in Seomyeon
- Choose a physician who explains how tirzepatide compares with semaglutide for you.
- Ask which product and approval (diabetes or weight management) applies to your prescription.
- Ask about contraception advice and pregnancy planning.
- Ask how dose escalation and side effects will be monitored.
- Ask about nutrition and exercise support to maintain muscle.
Ongoing care
Monthly reviews during dose escalation are typical. Seomyeon's central location makes regular visits manageable for people living across Busan.
Key facts
- Drug: tirzepatide, dual GIP and GLP-1 receptor agonist
- Dosing: once weekly subcutaneous injection
- Titration: starts at 2.5 mg, increases by 2.5 mg about every 4 weeks as tolerated
- Uses: type 2 diabetes and, where approved, chronic weight management
- Common side effects: nausea, diarrhea, vomiting, constipation, reduced appetite
- Not for: pregnancy, personal or family history of medullary thyroid cancer or MEN2
- Typical NHI coverage: generally paid privately when used for weight management
Frequently asked questions
Mounjaro vs Wegovy: which is more effective?
In trials, tirzepatide (Mounjaro) has produced greater average weight loss than semaglutide (Wegovy), though individual results vary. Side effects are similar. Your doctor will consider your health, tolerance and availability when choosing.
How does Mounjaro work?
Tirzepatide activates two gut hormone receptors, GIP and GLP-1, which reduce appetite, increase fullness, slow stomach emptying and improve insulin response. Together these effects lower calorie intake and blood sugar.
What are the side effects of Mounjaro?
The most common are nausea, diarrhea, vomiting, constipation and reduced appetite, especially when increasing doses. Rare but serious effects include pancreatitis and gallbladder problems. Report severe abdominal pain promptly.
Does Mounjaro affect birth control pills?
Tirzepatide can reduce absorption of oral contraceptives, particularly when starting or increasing the dose. Additional or non-oral contraception may be advised during these periods. Discuss this with your doctor.
Will I need Mounjaro forever?
Not necessarily, but obesity is a chronic condition and many people regain weight after stopping. Some continue at a maintenance dose; others taper with strong lifestyle support. Your doctor will help plan this.
Medical disclaimer: Seomyeon.Clinic is an independent information directory. Content is for general education and does not replace a consultation with a licensed physician. Suitability, risks, results and costs vary by person and clinic. In an emergency in Korea, call 119.